Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Spyre Therapeutics' CEO Sells 15,000 Shares

TheMotleyFool

0 0

Spyre Therapeutics' CEO Sells 15,000 SharesPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

This biotech innovator in antibody therapies for inflammatory bowel disease reported a notable insider sale, according to a new SEC filing.

Cameron Turtle, Chief Executive Officer of Spyre Therapeutics (NASDAQ:SYRE), directly sold 15,000 shares in open-market transactions on Jan. 2, for a total consideration of more than $460,000 according to a SEC Form 4 filing.

Transaction value based on SEC Form 4 weighted average purchase price ($30.68); post-Transaction value based on Jan. 2, 2026 market close ($30.58).

Source Fool.com

Like: 0

SYRE

Teilen